Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases [Sudan Tribune]

Press/Media

Period19 Jan 2019

Media coverage

1

Media coverage